Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
Guido Rindi, Massimo Falconi, Catherine Klersy, et al.
JNCI Journal of the National Cancer Institute (2012) Vol. 104, Iss. 10, pp. 764-777
Open Access | Times Cited: 445

Showing 1-25 of 445 citing articles:

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
Massimo Falconi, Barbro Eriksson, Gregory Kaltsas, et al.
Neuroendocrinology (2016) Vol. 103, Iss. 2, pp. 153-171
Open Access | Times Cited: 1233
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
Marianne Pavel, Dermot O’Toole, Frederico Costa, et al.
Neuroendocrinology (2016) Vol. 103, Iss. 2, pp. 172-185
Closed Access | Times Cited: 955
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Marianne Pavel, Kjell Öberg, M. Falconi, et al.
Annals of Oncology (2020) Vol. 31, Iss. 7, pp. 844-860
Open Access | Times Cited: 851
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
Rocio García‐Carbonero, Halfdan Sørbye, Éric Baudin, et al.
Neuroendocrinology (2016) Vol. 103, Iss. 2, pp. 186-194
Open Access | Times Cited: 563
Gastroenteropancreatic Neuroendocrine Tumors
Mauro Cives, Jonathan Strosberg
CA A Cancer Journal for Clinicians (2018) Vol. 68, Iss. 6, pp. 471-487
Open Access | Times Cited: 497
Population-Level Analysis of Pancreatic Neuroendocrine Tumors 2 cm or Less in Size
Eric J. Kuo, Ronald R. Salem
Annals of Surgical Oncology (2013) Vol. 20, Iss. 9, pp. 2815-2821
Closed Access | Times Cited: 217
Grading the neuroendocrine tumors of the lung: an evidence-based proposal
Guido Rindi, Catherine Klersy, Frediano Inzani, et al.
Endocrine Related Cancer (2013) Vol. 21, Iss. 1, pp. 1-16
Open Access | Times Cited: 208
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi, Ta‐Chiang Liu, Justin L. Roncaioli, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 2, pp. 600-609
Open Access | Times Cited: 206
Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications
Günter Klöppel
Visceral Medicine (2017) Vol. 33, Iss. 5, pp. 324-330
Open Access | Times Cited: 199
Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical Practice
Giuseppe Pelosi, Guido Rindi, William D. Travis, et al.
Journal of Thoracic Oncology (2014) Vol. 9, Iss. 3, pp. 273-284
Open Access | Times Cited: 187
The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia
Frediano Inzani, Gianluigi Petrone, Guido Rindi
Endocrinology and Metabolism Clinics of North America (2018) Vol. 47, Iss. 3, pp. 463-470
Closed Access | Times Cited: 181
Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future
Stefano La Rosa
Endocrine Pathology (2023) Vol. 34, Iss. 1, pp. 79-97
Open Access | Times Cited: 42
Neuroendocrine tumor disease: an evolving landscape
Andrea Frilling, Göran Åkerström, Massimo Falconi, et al.
Endocrine Related Cancer (2012) Vol. 19, Iss. 5, pp. R163-R185
Open Access | Times Cited: 164
The 2010 WHO Classification of Digestive Neuroendocrine Neoplasms: a Critical Appraisal four years after Its Introduction
Guido Rindi, Gianluigi Petrone, Frediano Inzani
Endocrine Pathology (2014) Vol. 25, Iss. 2, pp. 186-192
Closed Access | Times Cited: 159
Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms
Stefano Partelli, Roberto Cirocchi, Stefano Crippa, et al.
British journal of surgery (2016) Vol. 104, Iss. 1, pp. 34-41
Closed Access | Times Cited: 157
Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria—What has changed and why?
Luca Bertero, Federica Massa, Jasna Metović, et al.
Virchows Archiv (2017) Vol. 472, Iss. 4, pp. 519-531
Closed Access | Times Cited: 157
Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms
Günter Klöppel, Stefano La Rosa
Virchows Archiv (2017) Vol. 472, Iss. 3, pp. 341-349
Closed Access | Times Cited: 146
Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts
Joo Young Kim, Seung‐Mo Hong
Archives of Pathology & Laboratory Medicine (2016) Vol. 140, Iss. 5, pp. 437-448
Open Access | Times Cited: 139
Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement
Volkan Adsay, Pelin Bağcı, Takuma Tajiri, et al.
Seminars in Diagnostic Pathology (2012) Vol. 29, Iss. 3, pp. 127-141
Closed Access | Times Cited: 138
Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis
Emanuele Leoncini, Greta Carioli, Carlo La Vecchia, et al.
Annals of Oncology (2015) Vol. 27, Iss. 1, pp. 68-81
Open Access | Times Cited: 137
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management
Zuyi Ma, Yuanfeng Gong, Hongkai Zhuang, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 19, pp. 2305-2322
Open Access | Times Cited: 135
Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role
Arne Warth, Judith Cortis, Alex Soltermann, et al.
British Journal of Cancer (2014) Vol. 111, Iss. 6, pp. 1222-1229
Open Access | Times Cited: 132
Neuroendocrine Tumors of the Pancreas: Current Concepts and Controversies
Michelle D. Reid, Serdar Balcı, Burcu Saka, et al.
Endocrine Pathology (2014) Vol. 25, Iss. 1, pp. 65-79
Closed Access | Times Cited: 127
Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems
Guopei Luo, Ammar A. Javed, Jonathan Strosberg, et al.
Journal of Clinical Oncology (2016) Vol. 35, Iss. 3, pp. 274-280
Closed Access | Times Cited: 126
Surgical and molecular pathology of pancreatic neoplasms
Wenzel M. Hackeng, Ralph H. Hruban, G. Johan A. Offerhaus, et al.
Diagnostic Pathology (2016) Vol. 11, Iss. 1
Open Access | Times Cited: 122
Page 1 - Next Page

Scroll to top